** Increase fat stores

** Increase uterine growth

** Increase vaginal lubrication

** Increase hepatic production of binding proteins

** Increase circulating level of factors 2, 7, 9, 10, plasminogen

** Increase HDL, triglyceride

** Increase cortisol, SHBG

** Increase cholesterol in bile

** Increase pheomelanin, reduce eumelanin

** Increase awareness about violence against women and girls

** Increase awareness about HIV & AIDS as it relates to females.

** Increase awareness about women ’ s land rights.

** Increase awareness about women ’ s leadership, or lack of leadership in the political sphere.

** The accumulation of platelets to the site of a wound to form a platelet plug or a thrombus

** platelet count < 80, 000 / mm < sup > 3 </ sup > or 50 % drop from maximum in chronically thrombocytopenic patients, OR

** Decreased platelet count (< 50 x 10 < sup > 9 </ sup >/ L )

** Grey platelet syndrome

** platelet GPIb-receptor

** HELLP is characterized by hemolysis on peripheral blood smear with serum lactate dehydrogenase > 600 IU / L ; serum aspartate aminotransferase > 70 IU / L ; and platelet count < 100, 000 / μL.

** " The diagnosis of HELLP syndrome required the presence of thrombocytopenia ( perinatal platelet nadir ≤ 150, 000 cells / μL ), evidence of hepatic dysfunction ( increased aspartate aminotransferase level of ≥ 40 IU / L, increased alanine aminotransferase level of ≥ 40 IU / L, or both, with increased lactate dehydrogenase level of ≥ 600 IU / L ), and evidence of hemolysis ( increased LDH level, progressive anemia )...."

** " Class 1 HELLP syndrome featured severe thrombocytopenia with a platelet nadir of ≤ 50, 000 cells / μL, class 2 HELLP syndrome featured moderate thrombocytopenia with a platelet nadir between > 50, 000 and ≤ 100, 000 cells / μL, and class 3 HELLP syndrome featured mild thrombocytopenia with a platelet nadir between > 100, 000 and ≤ 150, 000 cells / μL.

** Myelotoxicity or bone marrow suppression, potentially leading to thrombocytopenia or blood platelet deficiency and / or leukopenia or white blood cell ( WBC ) deficiency

** low platelet counts ( leading to easy bruising and bleeding )

** Decreased platelet count causing increased risk of bleeding

Increase platelet counts can be due to a number of disease processes:

The antithrombotic effect of dextran is mediated through its binding of erythrocytes, platelets, and vascular endothelium, increasing their electronegativity and thus reducing erythrocyte aggregation and platelet adhesiveness.